Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



The therapeutic effect of naringin on ovarian and lung damages created by adnexal torsion/detorsion: A biochemical study

Emsal Pinar Topdagi Yilmaz, Ayhan Tanyeli, Fazile Nur Ekinci Akdemir, Ersen Eraslan, Mustafa Can Guler, Yunus Emre Topdagi.




Abstract
Cited by 0 Articles

Aim: In this study, naringin was examined against injuries in lung and ovarian tissues caused by ovarian torsion/detorsion (T/D).
Material and Methods: The animals were grouped as sham, T/D, 50 mg/kg Naringin and 100 mg/kg Naringin. In sham group, the abdomen was incised and then sutured but T/D model wasn’t performed. In T/D group, torsion and detorsion (ischemia 3 hours/reperfusion 3 hours) were carried out. In naringin treatment groups, naringin was applied intraperitoneally at the doses of 50 and 100 mg/kg about 30 minutes prior to detorsion. After detorsion period, experimental animals were immolated and the ovarian and lung tissues were excised, homogenized and the biochemical analyzes were done.
Results: The activity of MPO, IL-1β, MDA, TNF-α levels, TOS and OSI parameters raised significantly but SOD activity and TAS values declined in T/D group when it is compared to sham group. On the other side, naringin treatments reversed these parameters.
Conclusion: Thereby, naringin demonstrated therapeutic effect against the injuries of ovarian and lung tissues in rat T/D model.

Key words: Lung; naringin; ovary; rat; torsion/detorsion






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.